Bioelectronics Corp (BIEL)

[walker_429]

Greenwood may help us? WHEN ???? It's almost been a year...( in a sarcastic tone )

http://finance.yahoo.com/news/Greenwood-Group-to-Manage-iw-1193120821.html?x=0&.v=1

Looks like Biel again drove me to have a few drinks today ...LOL ( not celebrating but being sarcastic ).

Just curious....Has anyone asked this Paul Knopick from E&E communications whether or not he is buying shares? ( especially at this pps)

Paul wrote up and sent via e-mail this Due Diligence Market Summary on Biel which reminded me of Joe Noel's Emerging Growth Research Report right around the same PPS (price per share) so it's like Dejavu all over again. ( an old post of mine #1583 under janice2chase )
However if you read Pauls e-mail summary, you will see that through out the report the word Heat and Deep Heat Therapy appear frequently....
" The devices use proven therapies of heat and electric restoration of the body’s injured cells." and
" The extended duration dual therapy of heat and electric restoration is significantly safer and more effective than competitive heat or cold pads and pain medications."
"Heat Therapy - The use of pulsed electromagnetic therapy to generate heat in the body is significantly safer and more effective than topical heat or cold applications. The device uses radio frequency to penetrate and bypass the skins temperature regulatory mechanism. The microchip controls the RF dose to preclude excessive heat accumulation. The use of heat as a therapeutic agent has precedence as far back as traditional Chinese, Hindu and ancient Greek medicine, but recent biological research has provided a strong scientific foundation for the efficacy of this therapeutic modality. Medical diathermy, the use of electrical devices to push heat deep into the body, is as old as radio."
"Eighty years ago, clinicians started pulsing the heat into the body to preclude burning the patients."
" Increasing the RF pulse rate and you achieve a safe, steady, and controlled deep heating affect and maintain the non-thermal electrical affect."
"In traditional diathermy, the heating doses used are very high to minimize clinical and operator treatment time. Lowering the dose down to the level necessary to stimulate a biological responsse, sustains pain refief and enables home use. Now the device can be battery operated utilize inexpensive wafer thin microhip electronics, allowing the device to lay directly over the injured tissue for maximum effectivenes. Clinical studies demonstrate superior pain relief and healing with lower power and extended duaration therapy. The dual thermal and electrical therapy of diathermy provides a a unique, dynamic approach to the reducttion of pain, inflammation and the acceleration of healing."
"Tissue temperature increases can have several distinct effects on tissue behavior, though to a large degree, all of the physiologic effects of increasing the temperature of a biological tissue relate to conformational changes in protein and/or lipid structures and organization. Metabolic activities of all cellular processes are directly affected by tissue temperature and the change in biochemical activity that is directly related to tissue temperature. In brief, recent molecular biological, electrophysiological, and clinical research has demonstrated that the peripheral neural system is highly temperature sensitive, and many other specific sites and mechanisms of thermal sensitivity have been identified. This recent research points to a consensus understanding that a useful working range for ensuring significant biological responses to tissue heating is that the usual tissue temperature of 37oC should be raised at least 0.1oC. At the same time, the tissue temperature must be kept below 42oC to prevent cell damage. Application of these observations to the clinical setting suggests that a margin of safety be incorporated to ensure both the safety and efficacy of thermal therapeutics. Therefore, when core tissue heating is the objective, safe and efficacious tissue temperature increases should be kept in the range of approximately 0.3-3oC. "

Biel has even filed a patent for this technology: http://finance.yahoo.com/news/BioElectronics-Files-FDA-iw-2678015473.html?x=0&.v=1 .

So if this is the case then the Actipatch and Allay would be automatically classified Class II according to the FDA code regulations: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRsearch.cfm?FR=890.5290

IMO the ability to claim Heat as part of the Actipatch therapy to relieve pain and swelling is important to the companies value and marketing of the product. This may be the delay and well worth the delay to have such a claim cleared by the FDA for package labeling.
On the same note , Recovery RX may want to have an FDA claim that it accelerates healing , reduces bruising and Scarring :

http://www.amazon.com/Actipatch-C-Section-Swelling-Bruising-Scarring/dp/B004FRLRP6/ref=sr_1_10?ie=UTF8&qid=1332377379&sr=8-10 .

Imagine doctors being able to prescribe to woman a product that prevents and reduces the appearance of scars after a C-section ( Recovery RX ) so close to the bikini area and that will be covered by insurance.
So Again, the company value increases by having products cleared by the FDA with such claims. With the clinical studies coming to a close it may be worth the wait.

With all that is happening in the background I still feel the companies market cap is way undervalued and will continue to buy shares at this level. If approvals come with the claims and indications as described I would value this company in the 500 million - 750 million range which would make current share price at least .25 ( 625,000,000) .

Sorry to ramble on but I'm just trying to shed some positive light on the current situation.